Clinical Trial Update: CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating the combination of capivasertib, venetoclax, and low-intensity chemotherapy in adults with acute lymphoblastic leukemia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Lymphoblastic Lymphoma

Drugs mentioned

• Capivasertib (capivasertib)
• Venetoclax (venetoclax)

Snippet

Sponsor: University of Chicago | Conditions: Leukemia, Lymphoma | Phase 1, Phase 2 | Status: RECRUITING